25 Thus, GLP-1 could help to slow the progression of AD
R., Xie, F., Yun, H., Bernatsky, S
Images with fewer than five mitochondria were discounted
Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects
In a further aspect, the presently described technology provides a method for delivering amphetamine, comprising providing a human or animal patient with a therapeutically effective amount of at least one polar hydrophilic conjugate of amphetamine, which can provide a therapeutically bioequivalent area under the curve (AUC) when compared to free amphetamine, but does not provide a concentration max (C max ) which results in an increased heart rate, increased blood pressure or drug related euphoria when taken orally